These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26227247)

  • 1. Molecular Therapy Special Issue on Gene Editing Technologies and Applications.
    Frederickson R; Ylä-Herttuala S
    Mol Ther; 2015 Aug; 23(8):1279. PubMed ID: 26227247
    [No Abstract]   [Full Text] [Related]  

  • 2. Delivery technologies for genome editing.
    Yin H; Kauffman KJ; Anderson DG
    Nat Rev Drug Discov; 2017 Jun; 16(6):387-399. PubMed ID: 28337020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantifying on- and off-target genome editing.
    Hendel A; Fine EJ; Bao G; Porteus MH
    Trends Biotechnol; 2015 Feb; 33(2):132-40. PubMed ID: 25595557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urgency to rein in the gene-editing technology.
    Zhang X
    Protein Cell; 2015 May; 6(5):313. PubMed ID: 26131459
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetic correction using engineered nucleases for gene therapy applications.
    Li HL; Nakano T; Hotta A
    Dev Growth Differ; 2014 Jan; 56(1):63-77. PubMed ID: 24329887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From Genomics to Gene Therapy: Induced Pluripotent Stem Cells Meet Genome Editing.
    Hotta A; Yamanaka S
    Annu Rev Genet; 2015; 49():47-70. PubMed ID: 26407033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salient Features of Endonuclease Platforms for Therapeutic Genome Editing.
    Certo MT; Morgan RA
    Mol Ther; 2016 Mar; 24(3):422-9. PubMed ID: 26796671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Going Germline: Mitochondrial Replacement as a Guide to Genome Editing.
    Adashi EY; Cohen IG
    Cell; 2016 Feb; 164(5):832-5. PubMed ID: 26919419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mini enzyme moves gene editing closer to the clinic.
    Ledford H
    Nature; 2015 Apr; 520(7545):18. PubMed ID: 25832387
    [No Abstract]   [Full Text] [Related]  

  • 10. Gene therapy.
    Małecki M
    Med Wieku Rozwoj; 2013; 17(3):189-90. PubMed ID: 24296441
    [No Abstract]   [Full Text] [Related]  

  • 11. Responsible Use of Human Gene-Editing Technologies.
    Dzau VJ; Cicerone RJ
    Hum Gene Ther; 2015 Jul; 26(7):411-2. PubMed ID: 26176431
    [No Abstract]   [Full Text] [Related]  

  • 12. [Construction and control of synthetic genetic circuits].
    Sekine R; Kiga D
    Seikagaku; 2014 Apr; 86(2):201-8. PubMed ID: 24864447
    [No Abstract]   [Full Text] [Related]  

  • 13. Gene therapy: editorial control.
    Gammon K
    Nature; 2014 Nov; 515(7526):S11-3. PubMed ID: 25390136
    [No Abstract]   [Full Text] [Related]  

  • 14. Application of CRISPR/Cas9 genome editing to the study and treatment of disease.
    Pellagatti A; Dolatshad H; Valletta S; Boultwood J
    Arch Toxicol; 2015 Jul; 89(7):1023-34. PubMed ID: 25827103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome engineering in ophthalmology: Application of CRISPR/Cas to the treatment of eye disease.
    Hung SSC; McCaughey T; Swann O; Pébay A; Hewitt AW
    Prog Retin Eye Res; 2016 Jul; 53():1-20. PubMed ID: 27181583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of gene-editing technologies to HIV-1.
    Drake MJ; Bates P
    Curr Opin HIV AIDS; 2015 Mar; 10(2):123-7. PubMed ID: 25612322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethical and Societal Questions Loom Large as Gene Editing Moves Closer to the Clinic.
    Hampton T
    JAMA; 2016 Feb; 315(6):546-8. PubMed ID: 26810772
    [No Abstract]   [Full Text] [Related]  

  • 18. [Results of comprehensive management of patients with chronic lower limb ischaemia using gene-engineering technologies of angiogenesis stimulation (Part 2)].
    Gavrilenko AV; Voronov DA
    Angiol Sosud Khir; 2015; 21(4):29-35. PubMed ID: 26673292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harnessing the Power of Genetic Engineering for Patients With Mitochondrial Eye Diseases.
    Yu-Wai-Man P
    J Neuroophthalmol; 2017 Mar; 37(1):56-64. PubMed ID: 28187082
    [No Abstract]   [Full Text] [Related]  

  • 20. Progresses towards safe and efficient gene therapy vectors.
    Chira S; Jackson CS; Oprea I; Ozturk F; Pepper MS; Diaconu I; Braicu C; Raduly LZ; Calin GA; Berindan-Neagoe I
    Oncotarget; 2015 Oct; 6(31):30675-703. PubMed ID: 26362400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.